IMU imugene limited

1.41%

7.0¢

Imugene Small Caps Presentation, page-23

First 23 Last

Share
Profile

Follow
mattdamon

3,618 Posts.

59

04/04/18

11:04

Post #: 32207245
Share

Originally posted by supercendol ↑

Hi all,

Thank you for your kind words.

Additional info I gathered yesterday + my opinion:

There was a potential investor who went there for Acrux (ACR) presentation but became attracted to Imugene because of its potential. He tried to place a dollar value on IMU SP, which was not unlike us, Few Pennies for example. Interestingly, but probably not significant, Leslie responded that she thought Imugene has the potential to reach $1. I can't recall whether she said this 'before she joined' or 'after she joined'.

Anyway, just like any other pennystock investment, there's always a significant risk - market doesn't tolerate failure & will punish severely, sometimes beyond the fundamental value of the company. The contrast between ACR & IMU current SP opened my eyes about this. ACR has a cash reserve of $32m but an MC of only $25m. On the other hand IMU with $11m but $100m MC.

The presenter of ACR presentation, Michael Kotsanis, said this was due to recent termination of a licensing agreement with their big pharma partner, Eli Lilly. Michael tried to promote ACR pipelines & potentials so it's difficult for him to explain how it's possible for a company to have an MC lower than the cash reserve. Maybe it's a good buying opportunities? But I'm really not into pennystock except IMU.

So, we have a massive potential on one hand if IMU is successful & a big fall on the other for undesirable results. Remember to always be responsible on your investment (I really should say this to myself everyday, shouldn't I?).

Take care!

Expand

$1 or $2.8 (say 3) Billion dollar company. Stop it super or I'll have to post another purple eggplant.

IMU Price at posting: 3.6¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

4DX

4DMedical posts FY26 revenue growth as commercial deployment ramps up

D3E

D3 Energy detects gas in South African helium hunt well

SEN

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

IMR

Imricor Med and Philips launch commercial iMR lab solution

CVL

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

NVA

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

AS2

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

MEM

Memphasys receives early Thai FDA Felix approval

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

First 23 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 7.0¢		Change -0.001(1.41%)		Mkt cap ! $34.77M

Open	High	Low	Volume
7.1¢	7.3¢	7.0¢	1.459M

Buyers (Bids)

Vol.	Price($)
317435	7.0¢

Sellers (Offers)

Price($)	Vol.
7.2¢	122222

Last trade - 16.10pm 28/08/2026 (20 minute delay)

IMU (ASX) Chart

Imugene Small Caps Presentation, page-23

4DMedical posts FY26 revenue growth as commercial deployment ramps up

D3 Energy detects gas in South African helium hunt well

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

Imricor Med and Philips launch commercial iMR lab solution

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Memphasys receives early Thai FDA Felix approval

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Imugene Small Caps Presentation, page-23

Top Stories

4DMedical posts FY26 revenue growth as commercial deployment ramps up

D3 Energy detects gas in South African helium hunt well

Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline

Imricor Med and Philips launch commercial iMR lab solution

Civmec earnings: Profit climbs as $1.4b order book backs FY27 growth

Nova Minerals achieves key milestone on path to Alaskan antimony production

HotCopper Highlights Week 35: X2M, AnteoTech and Brighstar dominate forum chatter

Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus

Memphasys receives early Thai FDA Felix approval

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News